WM, H., LAA, B., & KMA, D. (2023). Aggressive versus indolent insulinomas: New clinicopathological insights. Endocrine-related cancer, 30(5), . https://doi.org/10.1530/ERC-22-0321
Chicago Style (17th ed.) CitationWM, Hackeng, Brosens LAA, and Dreijerink KMA. "Aggressive Versus Indolent Insulinomas: New Clinicopathological Insights." Endocrine-related Cancer 30, no. 5 (2023). https://doi.org/10.1530/ERC-22-0321.
MLA (9th ed.) CitationWM, Hackeng, et al. "Aggressive Versus Indolent Insulinomas: New Clinicopathological Insights." Endocrine-related Cancer, vol. 30, no. 5, 2023, https://doi.org/10.1530/ERC-22-0321.
Warning: These citations may not always be 100% accurate.